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A b s t r a c t: High-sensitivity C-reactive protein (CRP) has been extensively 
used in recent years to assess cardiovascular risk more thoroughly. A significant asso-
ciation between elevated CRP, a prevalence of coronary artery disease (CAD) and ad-
verse cardiac events has been found. Stress myocardial SPECT perfusion imaging 
(MPI) is an accurate noninvasive technique for detecting CAD. 
 The aim of our study was to find out if there are any differences in the CRP 
levels between patients with normal myocardial perfusion and mild to moderate per-
fusion defects, detected with 99m-Tc sestamibi gated SPECT MPI. 
We prospectively studied 127 patients (79 men, 48 women) suspected of ha-
ving CAD or with previously confirmed CAD, who were referred for MPI. According 
to the findings of the stress study, they were divided into two groups: with normal/ near 
normal myocardial perfusion (n = 85) and with a mild to moderate perfusion defect (n = 
42). Levels of CRP in the former group were significantly lower (2.7 mg/L vs. 4.2 
mg/L, p = 0.01). There were significantly more men (78.6% vs. 54%, p = 0.000*) and 
smokers (26% vs. 15%, p = 0.003), also the rates of PCI were significantly higher (36% 
vs. 15%, p = 0.006) in patients with mild to moderate perfusion defects. The two groups 
did not differ significantly in age, type of stress, presence of most risk factors for CAD, 
previous myocardial infarction and CABG.  
The results of our study have shown that patients with mild to moderate per-
fusion defects on stress myocardial perfusion SPECT imaging have significantly higher 
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levels of C-reactive protein, compared to those with normal/near normal myocardial 
perfusion. 
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Introduction 
 
There is extensive evidence that inflammation is a key pathogenetic me-
chanism in the development of atherosclerosis and in promoting its progression, 
leading finally to the atherothrombotic complications of cardiovascular disease 
[1, 2]. One of the serum markers that enables detection of the inflammation and 
is easy to measure is C-reactive protein (CRP), an acute-phase reactant.  
Introduction of the high-sensitivity CRP (hs-CRP) testing in recent 
years has given the investigators an opportunity to assess the cardiovascular risk 
more thoroughly. A significant association between elevated serum or plasma 
concentrations of hs-CRP, on the one hand, and the prevalence of coronary ar-
tery disease (CAD), the risk of recurrent cardiovascular events among those 
with established disease, and higher risk of severe cardiovascular events in 
apparently healthy individuals, on the other hand, has been documented in many 
studies [3–5].  
Some investigators claim that CRP is not merely an innocent bystander 
of the atherosclerotic process, but could play an active role in promoting vas-
cular inflammation, although this remains controversial [6]. 
For many years now, stress myocardial perfusion imaging (MPI) with 
radionuclides has been used as an accurate, well-established noninvasive techni-
que for detecting CAD. As the link between CRP and severe CAD has been de-
monstrated in the past [7], the aim of our study was to find out if there are any 
differences in the CRP levels between patients with normal myocardial perfu-
sion and mild to moderate perfusion defects, detected with 99m-Tc sestamibi 
gated SPECT myocardial perfusion imaging. 
 
 
Methods 
  
Study population 
This prospective study involved 127 patients (79 men, 48 women) sus-
pected of having CAD or with previously confirmed CAD, who were referred 
for myocardial perfusion imaging between December 2005 and July 2006 at the 
Pathophysiology and Nuclear Medicine Institute, Medical School in Skopje.  
Patients were selected on the basis of MPI findings: only those with 
normal myocardial perfusion and mild to moderate perfusion defects on the 
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stress images entered the study. Patients were not enrolled if they had had recent 
myocardial infarction or coronary revascularization (within 6 months), left 
bundle branch block, dilated cardiomyopathy or if they suffered from any acute 
or chronic infection and inflammation, uncontrolled hypertension (BP > 21/12 
kPa), chronic hepatic or renal disease. 
In 58 patients an exercise treadmill test was performed, and the rest 
were stressed with dipyridamole as a pharmacological stressor because were una-
ble to exercise for various reasons (e.g. poor condition, older age, comorbidity). 
A detailed questionnaire which included clinical, historical and stress 
data was filled in, with particular attention to the risk factors for CAD, previous 
myocardial infarction (MI) and coronary revascularization. 
 
Rest imaging 
A one-day rest-stress protocol with 99m-Tc sestamibi was performed in all 
patients. For the rest study 10–12 mCi of the tracer were injected intravenously, un-
der fasting conditions. Imaging started at least 1 hour after radioisotope injection. 
 
Exercise myocardial perfusion protocol 
Those who were able to exercise underwent a symptom-limited exercise 
treadmill test with the standard Bruce protocol. At near-maximal exercise, 
radiopharmaceutical (25 mCi) was injected intravenously and exercise was con-
tinued at maximal workload for one minute. SPECT acquisition was started 15 
to 30 minutes later. 
 
Dipyridamole myocardial perfusion protocol 
Patients who underwent dipyridamole stress were instructed not to con-
sume caffeine-containing products for 24 hours before testing.  
A dipyridamole infusion in doses of 0.56 mg/kg per body weight for 4 
minutes was given. At peak vasodilator effect (3 minutes after the end of the in-
fusion), 25 mCi of the tracer were injected. Two to three minutes later patients 
with side-effects were given aminophyllin as an antidote (125 to 250 mg). Re-
sults of blood pressure and 12-lead electrocardiograms were recorded at 2-mi-
nute intervals. Stress imaging started app.1 hour after the application of the 
radiopharmaceutical. 
 
Single photon emission computerized tomography (SPECT)  
All patients underwent ECG-synchronized acquisition (gated SPECT) 
for both studies with a rotating single head gamma-camera (Siemens e.cam Sig-
nature series).  
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Image interpretation 
Stress and rest images from the short-axis, horizontal long-axis and ver-
tical long-axis slices were compared by four experienced readers.  
The left ventricle was divided into 17 segments [8]. Quantitative ana-
lysis of the perfusional and functional parameters of the left ventricle during the 
rest and after stress was done with software package 4D-MSPECT. A summed 
stress score (SSS) was obtained automatically by means of adding the scores for 
the 17 segments of the stress images. A summed rest score (SRS) was similarly 
obtained by means of adding the scores for the 17 segments of the rest images. 
The sum of the difference between the stress and rest scores gave the summed 
difference score (SDS).  
 
C-reactive protein estimation 
Blood samples for high sensitive C-reactive protein (hs-CRP) testing were 
taken from all patients on the day of examination, in the morning. The sera were 
kept frozen at -20°C temperature until the assays were done. CRP levels in the sera 
were estimated with chemiluminescent immunometric assay (Immulite®/Immulite 
1000® High Sensitivity CRP),with an analytical sensitivity of 0.1 mg/L. 
 
Statistical analysis 
Continuous variables were expressed as mean value ± SD. The mean 
differences for continuous variables were compared by Student t test (2-tai-
led). Categorical variables were expressed as counts (percenttages) and com-
pared by means of a χ2 statistic. A p value < 0.05 was considered statistically 
significant. 
 
 
Results 
 
Patients’ characteristics 
The perfusional characteristics of the studied patients are shown in 
Table 1. According to the findings of MPI on the stress study, they were divided 
into two groups: group 1) with normal and near normal myocardial perfusion 
(SSS 0–3); and group 2) with a mild to moderate perfusion defect (SSS 4–13), 
as previously described (9). The two groups did not differ significantly in age, 
type of stress, presence of most risk factors for CAD, previous myocardial 
infarction and CABG. (Table 2). 
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Table 1 – Tabela 1 
 
Perfusional characteristics of the patients 
Perfuzioni karakteristiki na pacientite 
Variables (n = 127) Range 
SSS 3 ± 3.95 0–13 
SRS 2.4 ± 3.8 0–20 
SDS 1.4 ± 2.1 0–9  
SSS – summed stress score; SRS – summed rest score;  
SDS – summed difference score 
 
Table 2 – Tabela 2 
 
Characteristics of group 1 (SSS = 0–3) and group 2 (SSS = 4–13) 
Karakteristiki na grupa 1 (SSS = 0–3) i grupa 2 (SSS = 4‡13) 
Variables Group 1(n = 85) Group 2 (n = 42) p value 
Age (y) 56.8 ± 10 58,4 ± 9 0.38 
Hs-CRP 2.7 ± 2,3            4.2 ± 4.2 0.01 
Sex (No. of males) 46 (54%) 33 (78,6%) 0.000* 
Dipyridamole 43 (51%) 26 (62%) 0.2 
DM 13 (15%) 11 (26%) 0.14 
Hypertension 66 (78%) 33 (79%) 0.99 
Smokers   6 (7%) 11 (26%) 0. 003 
Hyperlipidaemia 23 (27%) 11/42 (26%) 0.9 
PVD 6 (7%) 6 (14%) 0.2 
Obesity 25 (29%) 18 (43%) 0.1 
Previous MI 14 (16%) 12 (28.6%) 0.1 
PCI 13 (15%) 15 (36%) 0.006 
CABG   3 (3%) 4 (9%) 0.15 
Hs-CRP – high sensitive C-reactive protein; DM – diabetes mellitus; PVD – peripheral 
vascular disease; MI – myocardial infarction; PCI – percutaneous coronary intervene-
tions; CABG – coronary artery by-pass grafting 
 
High sensitive C-reactive protein values 
Levels of hs-CRP in group 1, compared to group 2, were significantly 
lower (2.7 mg/L vs. 4.2 mg/L, p = 0.01). In group 2 there were significantly 
more men (78.6% vs. 54%, p = 0.000*) and smokers (26% vs. 15%, p = 0.003), 
also the rates of PCI were significantly higher (36% vs. 15%, p = 0.006). 
More profound differences in hs-CRP levels were found when patients 
with no perfusion defects in the stress study (group 1a, SSS = 0) were compared 
to group 2. The mean hs-CRP level in the former group was 2.4 mg/L (p = 
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0.008 vs. group 2). For the other variables similar results were obtained as 
previously between group 1 and group 2 (Table 3). 
 
Table 3 – Tabela 3  
 
Characteristics of group 1a (SSS = 0) and group 2 (SSS = 4–13) 
Karakteristiki na grupa 1a (SSS = 0) i grupa 2 (SSS = 4–13) 
Variables Group 1a (n = 57) Group 2 (n = 42) p value 
Age (y) 56.3 ± 10.4 58.4 ± 9 0.31 
Hs-CRP 2.4 ± 2              4.2 ± 4.2 0.008 
Sex (No. of males) 31 (54%) 33 (78.6%) 0.01 
Dipyridamole 28 (49%) 26 (62%) 0.2 
DM 8 (14%) 11 (26%) 0.12 
Hypertension 46 (80%) 33 (79%) 0.8 
Smokers 3 (5%) 11 (26%) 0.003 
Hyperlipidaemia 12 (21%) 11 (26%) 0.5 
PVD 3 (5%) 6 (14%) 0.13 
Obesity 18 (32%) 18 (43%) 0.24 
Previous MI 8 (14%) 12 (28.6%) 0.08 
PCI 7 (12%) 15 (36%) 0.006 
CABG 2 (3.5%)   4 (9%) 0.2 
   Abbreviations as in Table 2. 
 
 
Discussion 
 
Interest in inflammatory markers, especially for CRP as a novel marker 
in the assessment of cardiovascular risk and the presence of CAD, has gained 
great attention in the past few years [3, 6]. To the best of our knowledge, this is 
the first study that has looked into the levels of C-reactive protein in patients 
who have undergone MPI, and showed that even mild to moderate perfusion 
defects are followed with an increase of CRP.  
The only variables that were significantly different between the patients 
with normal/near normal myocardial perfusion and mild to moderate perfusion 
defects were male gender, percentage of smokers and percutaneous coronary 
interventions (PCI). Concerning the gender, it is well known that the prevalence 
of CAD among men is higher compared to women [10], which was again con-
firmed by the results of our study. 
Elevated levels of C-reactive protein, interleukin-6, fibrinogen and ot-
her inflammatory markers have been found in smokers in numerous studies, 
verifying a low-grade systemic inflammation in this population [11]. On the 
other hand, long-term smokers have a higher prevalence of atherosclerosis. In a 
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large group of patients with established coronary heart disease, Benderly et al. 
found that elevated CRP levels in both sexes were associated with smoking, co-
morbidities, lower education level, and the use of cardiovascular drugs [12]. 
This could explain to some extent the higher levels of CRP in our patients with 
mild to moderate perfusion defects. 
Results from the large prospective Prevention of Renal and Vascular 
Endstage Disease (PREVEND) study, in more than 8000 subjects without pre-
vious documented CAD, have shown that baseline CRP levels were associated 
with angiographic characteristics and clinical consequences of plaque instability 
in those who had coronary events and underwent coronary angiography during 
the follow up of 6 years [13]. CRP contributed significantly to the multivariate 
model after adjustment for age, gender, smoking, lipids and blood pressure. On 
the basis of these finding, we can speculate that higher CRP levels in our sub-
jects with perfusion defect may be associated with the process of atherosclerosis 
per se. 
Another potential confounding factor in our study was the increased 
rate of percutaneous coronary interventions (PCI) in patients with mild to mode-
rate perfusion defects. Systemic markers of inflammation increase after PCI and 
the rise in inflammatory markers after PCI is attributed to the inflammatory 
stimulus associated with coronary artery injury during balloon inflation and 
coronary stent implantation.  
It was shown that even diagnostic coronary angiography performed in 
patients with stable angina triggers a systemic inflammatory response [14]. In 
the same study there was a significant increase in CRP levels at 24 and 48 hours 
in both the coronary angiography group (patients who underwent only diagno-
stic coronary angiography) and PCI group (patients who underwent PCI). At 4 
weeks, CRP returned to baseline levels in both groups. Our study included only 
patients with remote PCI, a minimum of 6 months prior to the myocardial per-
fusion study. This period was long enough, we believe, for the inflammatory 
response related to PCI to subside. 
 
 
Conclusion 
 
The results of our study indicated that patients with mild to moderate 
perfusion defects on stress myocardial perfusion SPECT imaging have signi-
ficantly higher levels of C-reactive protein, compared to those with normal/near 
normal myocardial perfusion. 
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A p s t r a k t: Visoko senzitivniot C-reaktiven protein (CRP) vo 
poslednite godini ~esto se koristi za pokompletna procena na kardio-
vaskularniot rizik. Pronajdena e zna~ajna povrzanost pome|u poka~eniot 
CRP, od edna strana, i prevalencata na koronarnata arteriska bolest (KAB) 
i nesakanite srcevi zbidnuvawa, od druga strana. So stres miokardnata 
SPECT perfuziona scintitomografija (MPS) e potvrdena neinvazivna 
metoda za detekcija na KAB. 
Celta na studijata be{e da utvrdime dali postojat razliki vo ni-
voata na CRP pome|u pacientite so normalna miokardna perfuzija i onie 
so lesni do umereni perfuzioni ispadi, detektirani so 99m-Tc sestamibi gated 
SPECT MPS. 
Prospektivno bea ispitani 127 pacienti (79 ma`i, 48 `eni) sus-
pektni za KAB ili so prethodno potvrdena KAB, upateni za MPS. Sogla-
sno naodite od stres studijata, tie bea podeleni vo dve grupi: so normal-
na/skoro normalna miokardna perfuzija (n = 85) i so lesen do umeren per-
fuzionen ispad (n = 42). Vrednostite na CRP vo prvata grupa bea signifi-
kantno poniski (2,7 mg/L vs. 4,2 mg/L, p = 0,01). Zna~itelno pove}e ispita-
nici od grupata so lesen do umeren perfuzionen ispad bea ma`i (78,6% vs. 
54%, p = 0,000*) i pu{a~i (26% vs. 15%, p = 0,003), isto taka brojot na perku-
tanite koronarni intervencii (PKI) be{e zna~itelno povisok (36% vs. 
15%, p = 0,006). Ne be{e utvrdena zna~ajna razlika pome|u dvete grupi po 
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odnos na vozrasta, vidot na primenetiot stres, prisustvoto na pove}eto 
rizik faktori za KAB, kako i zastapenosta na miokardni infarkti i 
aorto-koronarni premostuvawa. 
Rezultatite od na{ata studija poka`aa deka pacientite so lesen do 
umeren perfuzionen ispad na stres miokardnata perfuzija imaat signifi-
kantno povisoki vrednosti na CRP, sporedeno so onie koi imaat nor-
malna/skoro normalna miokardna perfuzija. 
 
Klu~ni zborovi: C-reaktiven protein, koronarna bolest, dijagnosti~ki 
vizuelizacioni tehniki. 
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